C6 Modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorption
作者:Richard C.A. Isaacs、Kellie J. Cutrona、Christina L. Newton、Philip E.J. Sanderson、Mark G. Solinsky、Elizabeth P. Baskin、I-Wu Chen、Carolyn M. Cooper、Jacquelynn J. Cook、Stephen J. Gardell、S.Dale Lewis、Robert J. Lucas、Elizabeth A. Lyle、Joseph J. Lynch、Adel M. Naylor-Olsen、Maria T. Stranieri、Kari Vastag、Joseph P. Vacca
DOI:10.1016/s0960-894x(98)00297-2
日期:1998.7
1 (L-374,087) is a potent, selective, efficacious, and orally bioavailable thrombin inhibitor that contains a core 3-amino-2-pyridinone moiety. Replacement of the C6 pyridinone methyl group of 1 by a propyl group gave 5 (L-375,052), which retained all the excellent properties of 1, and also yielded higher plasma levels after oral dosing in dogs and rats. (C) 1998 Elsevier Science Ltd. All rights reserved.